Ian Ford

The Lancet · 2000–2021

A researcher in the Science corpus: 33 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Who trusts Ian Ford overall

  1. Michael R. Kosorok
  2. Irina Degtiar

Papers from Ian Ford's perspective

Ordered by how strongly the researchers Ian Ford trusts endorse each paper. Same corpus, a different order for every researcher.

  1. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (Journal of the American Medical Association (JAMA))
  2. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. (New England Journal of Medicine)
  3. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. (Archives of Internal Medicine)
  4. Women and Ischemic Heart Disease: Evolving Knowledge (Journal of the American College of Cardiology)
  5. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized… (Journal of the American College of Cardiology)
  6. Caveats for the Use of Operational Electronic Health Record Data in Comparative Effectiveness Research (Medical Care)
  7. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. (Diabetes)
  8. Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ (Science)
  9. The "meaningful use" regulation for electronic health records.
  10. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study (Circulation)

Their papers